Enhanced with market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, The Business Research Company’s 2026 market reports deliver more actionable and strategically valuable research.
Minimally Invasive Thoracic Surgery Market Size And Revenue Forecast Through 2030
The market for minimally invasive thoracic surgery has experienced robust expansion lately, projected to increase from $4.38 billion in 2025 to $4.74 billion in 2026, reflecting a compound annual growth rate (CAGR) of 8.2%. This historical growth trajectory is underpinned by a confluence of factors, including a rise in the prevalence of thoracic ailments, the proliferation of dedicated surgical facilities, advancements in minimally invasive surgical tools, enhanced training for surgeons in thoracoscopic methods, and a growing inclination among patients towards less invasive medical interventions.
Anticipate a robust expansion for the minimally invasive thoracic surgery market within the upcoming years, projecting a valuation of $6.46 billion by 2030. This growth trajectory, reflecting a compound annual growth rate of 8.1%, is underpinned by several key drivers including the escalating use of advanced robotic surgical systems, the growing incorporation of artificial intelligence in surgical planning, the proliferation of ambulatory thoracic surgery initiatives, a heightened demand for enhanced imaging capabilities, and an increasing emphasis on patient outcome-centered surgical approaches. Furthermore, significant developments poised to shape this period involve a greater embrace of robotic assistance in thoracic interventions, expanded utilization of sophisticated visualization technologies, a burgeoning preference for video-assisted methodologies, the wider deployment of precision energy instruments, and a stronger commitment to minimizing recovery periods following surgery.
Download A Free Sample Report For Comprehensive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=27348&type=smp
Minimally Invasive Thoracic Surgery Market Growth Factors: Which Forces Are Supporting Market Expansion?
The increasing prevalence of lung ailments is poised to be a significant catalyst for the expansion of the minimally invasive thoracic surgery sector. Lung conditions encompassing issues that compromise respiratory function and the ability to breathe, like asthma, chronic obstructive pulmonary disease (COPD), pneumonia, and malignant lung growths, are becoming more common. A primary driver behind this surge in lung disease is tobacco consumption, as the detrimental substances present in tobacco progressively harm the DNA within lung cells, thereby elevating the probability of aberrant cell proliferation and the development of neoplasms. Minimally invasive surgical approaches offer considerable benefits to individuals suffering from lung pathologies by precisely addressing and eradicating or obliterating tumors via diminutive incisions or image-guided instruments. This method translates to accelerated recuperation, minimized harm to healthy pulmonary tissue, a reduced likelihood of adverse events, and enables patients to reintegrate into their regular routines more swiftly. Illustratively, data from the Centers for Disease Control and Prevention, a federal agency in the United States, reveals that in 2022, the U.S. documented 218,893 new diagnoses of lung cancer, and by 2023, this disease tragically resulted in the demise of 131,584 individuals nationwide. Consequently, the escalating rate of lung disease occurrence is directly fueling the upward trajectory of the minimally invasive thoracic surgery market.
Minimally Invasive Thoracic Surgery Market Segment Analysis Highlighting Growth Areas
The minimally invasive thoracic surgery market covered in this report is segmented –
1) By Surgical Resection Type: Lobectomy, Wedge Resection, Pneumonectomy, Other Types
2) By Product: Energy Devices, Instruments, Staplers And Disposables, Visualization Systems
3) By Procedure Type: Video-Assisted Thoracoscopic Surgery (VATS), Robotic-Assisted Thoracic Surgery, Endoscopic Thoracic Surgery, Other Procedure Types
4) By Application: Lung Cancer Surgery, Esophageal Surgery, Mediastinal Surgery, Other Applications
5) By End-User: Hospitals, Specialty Clinics, Ambulatory Surgical Centers, Other End-Users
Subsegments:
1) By Lobectomy: Bilobectomy, Sleeve Lobectomy, Thoracoscopic Lobectomy (VATS Lobectomy), Robotic-Assisted Lobectomy
2) By Wedge Resection: Video-Assisted Thoracoscopic Surgery (VATS) Wedge Resection, Robotic-Assisted Wedge Resection, Open Wedge Resection
3) By Pneumonectomy: Standard Pneumonectomy, Extended Pneumonectomy, Sleeve Pneumonectomy, Thoracoscopic
4) By Other Types: Segmentectomy, Sleeve Resection, Decortication, Bullectomy, Thoracoscopic Resection For Metastasectomy
Minimally Invasive Thoracic Surgery Market Industry Trends: What Changes Are Reshaping Demand?
Within the realm of minimally invasive thoracic surgery, leading entities are channeling their efforts towards pioneering advancements, notably the integration of robotic-assisted surgical systems, aiming to elevate procedural precision and ultimately boost patient recovery results. A robotic-assisted surgical platform represents a sophisticated setup enabling surgeons to manipulate robotic instruments with exceptional accuracy for less invasive interventions, thereby augmenting precision, fine motor control, and visual clarity in contrast to conventional surgical methods. As an illustration, a significant development occurred in June 2024 when Monmouth Medical Centre, a healthcare provider situated in the United States, implemented the Ion Robotic platform, the Aliya PEF system, and advanced intraoperative CT scanning powered by artificial intelligence. This suite of technologies delivers advantages encompassing heightened surgical exactitude, improved patient prognoses, and immediate imaging feedback to facilitate more informed choices. Collectively, these innovations facilitate precise minimally invasive approaches for the diagnosis and management of lung cancer, leading to quicker recuperation periods and more favorable results; they facilitate real-time guidance, non-thermal destruction of tumors, and minimized radiation exposure, thereby encouraging prompt identification and comprehensive treatment.
Minimally Invasive Thoracic Surgery Market Leading Companies: Who Holds Significant Market Presence?
Major companies operating in the minimally invasive thoracic surgery market are Johnson And Johnson Services Inc., Medtronic Plc, Koninklijke Philips N.V., Stryker Corporation, GE Healthcare Inc., Olympus Corporation, Intuitive Surgical Operations Inc., Smith & Nephew plc, Teleflex Incorporated, Karl Storz SE & Co. KG, Cook Group Incorporated, CONMED Corporation, Applied Medical Resources Corporation, KLS Martin Group, Aesculap Inc., Medela Inc., Richard Wolf GmbH, B. Braun Melsungen AG, Ackermann Instrumente GmbH, Cmr Surgical, Genesee Biomedical Inc.
Access The Complete Minimally Invasive Thoracic Surgery Market Report:
Minimally Invasive Thoracic Surgery Market Geographic Landscape: Which Region Dominates Industry Growth?
North Americawas the largest region in the minimally invasive thoracic surgery market in 2025. Asia-Pacificis expected to be the fastest-growing region in the forecast period. The regions covered in the minimally invasive thoracic surgery market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
